Acquisitions and Divestiture (Tables)

12 Months Ended

Dec. 31, 2011

DxS Ltd and SABiosciences Corporation [Member]

Final Allocation of Purchase Price and Transaction Costs for Acquisitions of DxS and SABiosciences, Corbett and Biosystems Business

As of December 31, 2011, the preliminary purchase price allocations are as follows:

(in thousands)	Cellestis acquisition			Ipsogen acquisition			Total
Purchase price:
Cash consideration paid	$	372,452		$	57,436		$	429,888
Fair value of remaining shares	—			42,437			42,437
	$	372,452		$	99,873		$	472,325
Preliminary allocation:
Working capital	$	16,893		$	15,246		$	32,139
Fixed and other long-term assets	1,112			2,429			3,541
Developed technology, licenses and know-how	67,200			36,400			103,600
Customer relationships	42,600			10,600			53,200
Tradenames	12,000			1,500			13,500
Goodwill	270,860			52,095			322,955
Deferred tax liability on fair value of identifiable intangible assets acquired	(37,981		)	(16,485		)	(54,466		)
Liabilities assumed	(232		)	(1,912		)	(2,144		)
	$	372,452		$	99,873		$	472,325

Corbett Life Science Pty.Ltd and Biosystems Business [Member]

Final Allocation of Purchase Price and Transaction Costs for Acquisitions of DxS and SABiosciences, Corbett and Biosystems Business

As of December 31, 2010, the final allocation of the purchase price and transaction costs for the acquisitions of DxS and SABiosciences are follows:

(in thousands)	DxS Acquisition			SABiosciences Acquisition			Total
Purchase Price:
Cash consideration paid	$	94,823		$	97,586		$	192,409
Fair value of milestones	17,599			—			17,599
	$	112,422		$	97,586		$	210,008
Final Allocation:
Working capital	$	263		$	10,503		$	10,766
Fixed and other long-term assets	2,199			2,215			4,414
Product technology and know how	16,400			26,400			42,800
Purchased in-process research and development	1,400			1,700			3,100
Customer relationships	54,900			8,400			63,300
Tradename	4,100			1,900			6,000
Goodwill	55,417			62,433			117,850
Deferred tax liability on fair value of identifiable intangible assets acquired	(21,522		)	(15,965		)	(37,487		)
Liabilities assumed	(735		)	—			(735		)
	$	112,422		$	97,586		$	210,008